• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-21A
Device Problems Backflow (1064); Calcified (1077)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 11/19/2021
Event Type  Injury  
Manufacturer Narrative
An event of calcification and severe aortic insufficiency were reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported that on (b)(6) 2017, a 21 mm trifecta gt valve was implanted into a (b)(6) year old female patient in the aortic position.She had a concomitant coronary artery bypass graft (cabg).In (b)(6) 2021, the patient had a normal echocardiographic exam which showed a mean transvalvular gradient of 10 mmhg.On (b)(6) 2021, the patient had an acute cardiac decompensation with a transvalvular gradient of 55 mmhg and severe aortic insufficiency grade ii to grade iii.Calcification was observed on 3 commissures of the valve.There was no sign of infective endocarditis.On (b)(6) 2021, the 21 mm trifecta gt valve was explanted and replaced with a 21 mm non-abbott valve.The patient had a past medical history of tobacco use, dyslipidemia, hypertension, chronic obstructive pulmonary disease (copd), limited renal function, coronary artery disease (cad), and colon polyp removal.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
Manufacturer (Section G)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS   01897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key13111973
MDR Text Key282922677
Report Number3014918977-2021-00129
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018212
UDI-Public05415067018212
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/20/2018
Device Model NumberTFGT-21A
Device Catalogue NumberTFGT-21A
Device Lot Number5765498
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/20/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
Patient SexFemale
-
-